Calamos Advisors »

Royalty Pharma shares owned by Calamos Advisors

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $21M 437k 47.97

More positions owned by Calamos Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Western Digital Corp Note 3.000%11/1 (Principal)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Calamos Advisors

Top funds holding Royalty Pharma

Morgan Stanley
Capital Research and Management Company - Division 3
FMR
BlackRock
Baillie Gifford & Co
Adage Capital Partners GP
Swedbank AB
State Street Corporation
Vanguard Group
Capital World Investors
Geode Capital Management
Caledonia
Victory Capital Management
Vanguard Capital Management
Northern Trust

View all funds holding Royalty Pharma